CBIO
Crescent Biopharma
CBIO
CBIO
29 hedge funds and large institutions have $79.3M invested in Crescent Biopharma in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
29
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$856K | |
| 2 | +$226K | |
| 3 | +$143K | |
| 4 |
Renaissance Technologies
New York
|
+$74.9K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$59.1K |
Top Sellers
| 1 | -$1M | |
| 2 | -$196K | |
| 3 | -$48.5K | |
| 4 |
Morgan Stanley
New York
|
-$29.1K |
| 5 |
Citigroup
New York
|
-$11K |